Molecular Pathology of Lung Tumors
H Popper - Pathology of Lung Disease: Morphology–Pathogenesis …, 2021 - Springer
Within the last decade, many important discoveries were made in the regulation of growth,
differentiation, apoptosis, and metastasis of lung cancers. These findings have dramatically …
differentiation, apoptosis, and metastasis of lung cancers. These findings have dramatically …
Molecular Pathology of Lung Tumors
H Popper, H Popper - Pathology of Lung Disease: Morphology …, 2017 - Springer
Within the last decade, many important discoveries were made in the regulation of growth,
differentiation, apoptosis, and metastasis of lung cancers. These findings have dramatically …
differentiation, apoptosis, and metastasis of lung cancers. These findings have dramatically …
[图书][B] Novel Platinum (Pt)-Vandetanib Hybrid Compounds: Design, Synthesis and Investigation of Anti-cancer Activity and Mechanism of Action
R Fei - 2016 - search.proquest.com
Purpose: Lung cancer is one of the most common cancers and non-small cell lung cancer
(NSCLC) accounts for 80-85% of lung cancers. 70% of individuals with NSCLC harboring …
(NSCLC) accounts for 80-85% of lung cancers. 70% of individuals with NSCLC harboring …
Chemotherapeutic properties of epigallicatechin-3-gallate in lung carcinogenesis
M Cromie - 2016 - ttu-ir.tdl.org
Our previous study examined the role of natural products in the acute treatment of normal
human lung epithelial cells, BEAS-2B, to biologically relevant concentrations of BaP. Since …
human lung epithelial cells, BEAS-2B, to biologically relevant concentrations of BaP. Since …
The Importance of the Insulin-like Growth Factor Signaling Pathway in Lung Cancer and the Potential of its Components as Therapeutic Targets
SE Franks - 2015 - atrium.lib.uoguelph.ca
Lung cancer is the leading cause of cancer-related mortalities worldwide. Despite the
introduction of new therapeutics, there has been very little improvement in survival for …
introduction of new therapeutics, there has been very little improvement in survival for …
Second German-Catalan workshop on epigenetics & cancer
B Gonzalez, SV Forcales, M Perucho - Epigenetics, 2015 - Taylor & Francis
The Second German-Catalan Workshop on Epigenetics and Cancer was held in Barcelona
on November 19–21, 2014. The workshop brought together, for the second time, scientists …
on November 19–21, 2014. The workshop brought together, for the second time, scientists …
Novel and Emerging Agents in NSCLC
AS Tsao, JA Roth - Lung Cancer, 2014 - Wiley Online Library
This chapter will review the latest emerging novel targeted agents and gene therapy in
nonsmall cell lung cancer treatment. In the targeted therapies section, each class of drug will …
nonsmall cell lung cancer treatment. In the targeted therapies section, each class of drug will …
[PDF][PDF] Docteur en Sciences
ADELAP INTEGRATIVE - theses.hal.science
Le concept de la pathologie dite «intégrative» dans le domaine de l'oncologie est centré sur
la recherche pré clinique et/ou sur la recherche translationnelle, assurant le lien entre la …
la recherche pré clinique et/ou sur la recherche translationnelle, assurant le lien entre la …
Development and optimization of a methodology to synthetize chitosan/cetuximab conjugates for encapsulate siRNA and targeting to EGFR overexpressing cells
JAP Mota - 2014 - repositorio.cespu.pt
O uso terapêutico de Small Interfering RNA (siRNA) tem sido observado como uma
potencial nova abordagem para o tratamento do cancro. O desafio-chave no campo clínico …
potencial nova abordagem para o tratamento do cancro. O desafio-chave no campo clínico …
H προγνωστική σημασία των κυκλοφορούντων διαλυτών μορίων προσκόλλησης σε ασθενείς με μικροκυτταρικό καρκίνο πνεύμονα: συσχέτιση με κλινικές και …
Η Κοττέας - 2014 - didaktorika.gr
Σκοπός: Η επιθηλιακή Ε-καντερίνη, το διακυτταρικό μόριο προσκόλλησης-1 (ΙCAM-1),
τοαγγειακό μόριο προσκόλλησης-1 (VCAM-1) και η ενδοθηλιακή Ε-σελεκτίνη …
τοαγγειακό μόριο προσκόλλησης-1 (VCAM-1) και η ενδοθηλιακή Ε-σελεκτίνη …